Bottom line
AKRE vs FCUEX: the short answer
AKRE (Akre Focus ETF) and FCUEX (NYLI PineStone U.S. Equity Fund) are both etfs.
AKRE is cheaper at 0.98% vs 0.99% — a difference of $1.00 a year per $10,000 invested.
Over five years, AKRE returned +12.1% a year vs +10.3% for FCUEX (reporting dates differ).
FCUEX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
AKRE vs FCUEX side by side
| AKRE | FCUEX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Tortoise | New York Life Investments |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.98% | 0.99% |
| Annual cost per $10k | $98 | $99 |
| 10-yr cost on $10k (prospectus) | — | $1,696 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +18.3% | +1.7% |
| 5-yr return (annualized) | +12.1% | +10.3% |
| 10-yr return (annualized) | +14.0% | — |
| Best quarter | +21.7% | — |
| Worst quarter | −13.0% | — |
| Net assets (fund) | $5.2B | $382.2M |
| Number of holdings | 19 | 25 |
| Portfolio turnover | 6% | 15% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
3 of AKRE's top 19 holdings also appear in FCUEX's top 25.
| Holding | AKRE | FCUEX |
|---|---|---|
| Mastercard Inc | 14.24% | 6.45% |
| Moody's Corp | 6.94% | 7.13% |
| Copart Inc | 3.88% | 1.95% |
Source: SEC Form N-PORT
AKRE top 10
- Mastercard Inc — 14.24%
- Constellation Software Inc/Can — 12.68%
- Brookfield Corp — 7.33%
- Topicus.com Inc — 7.33%
- Roper Technologies Inc — 7.29%
- Visa Inc — 7.24%
- KKR & Co Inc — 7.22%
- Moody's Corp — 6.94%
- Fair Isaac Corp — 5.96%
- CoStar Group Inc — 4.65%
FCUEX top 10
- Alphabet, Inc. — 9.84%
- Microsoft Corp. — 8.99%
- Amazon.com, Inc. — 7.20%
- Moody's Corp. — 7.13%
- Mastercard, Inc. — 6.45%
- Analog Devices, Inc. — 5.10%
- AutoZone, Inc. — 4.74%
- CME Group, Inc. — 4.52%
- KLA Corp. — 4.38%
- Linde plc — 3.64%
FAQ
What is the difference between AKRE and FCUEX?
Which is cheaper, AKRE or FCUEX?
Should I own both AKRE and FCUEX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.